Sotelix was founded in March 2024. Credit: Andrey Zhernovoy via Shutterstock.

Sotelix Endoscopy has completed a $1.7m funding round that will go towards research, development and the in vivo testing of its therapeutic endoscopy devices.

The Baltimore, US-based company said the funding round included participation from individual investors, entrepreneurs, and other unspecified investors with clinical, technical and business expertise. The company is currently developing a therapeutic endoscope for procedures dependent on the closure of tissue of the gastrointestinal (GI) tract that is designed to allow for procedures to be performed in a minimally invasive manner without the need for incisions.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Sotelix was founded in March 2024 by Dr Mouen Khashab, a professor of medicine at Johns Hopkins University’s (JHU) School of Medicine, who serves as the company’s president. A recognised leader in therapeutic endoscopy, Dr Khashab has authored more than 575 publications and holds over ten endoscopic instrument patents.

The Sotelix team consists of co-founder Dr Venkata Akshintala, associate professor at JHU’s School of Medicine, entrepreneur Mohamad Khachab as chairman and CEO John Schellhorn.

Dr Khashab commented: “Therapeutic endoscopy holds the potential to treat numerous gastrointestinal conditions in a minimally invasive manner, but achieving this requires the right tools.

“Sotelix is dedicated to creating these tools to enable incision-free, scar-free treatments, helping patients return to their lives faster.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to GlobalData analysis, the global endoscopy devices market was valued at around $15.76bn in 2023. Growing at a compound annual growth rate of 5.7%, it is forecast to reach a valuation of around $28.94bn by 2033.

Elsewhere in endoscopy, this month Swedish company Alleima acquired Germany-headquartered Endox, a manufacturer that supplies nitinol and stainless-steel products and components across fields including endoscopy and gastroenterology.

In November, Medtronic acquired Netherlands-based Fortimedix Surgical in a bid to boost its surgical and endoscopy portfolio.